Table 1.

Implant Alone Versus Combination Implant and External Beam Radiotherapy

Low Risk—Implant Alone	Intermediate and High Risk—EBRT and Implant
Clinical stage T1 or T2a, T2b	Clinical stage > T2c
Gleason score ≤ 6	Gleason score ≥ 7
PSA ≤10 ng/mL	PSA > 10 ng/mL
Exceptions	Exceptions
T2a, T2b	T1c, T2a, Gleason score 7
> 66% biopsies positive	< 34% biopsies positive
EBRT and implant	Implant alone

EBRT, external beam radiotherapy; PSA, prostate-specific antigen